These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 34742130)

  • 1. Complex immune deregulation in severe COVID-19: More than a mechanism of pathogenesis.
    Giamarellos-Bourboulis EJ
    EBioMedicine; 2021 Nov; 73():103673. PubMed ID: 34742130
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
    Kumar A; Prasoon P; Sekhawat PS; Pareek V; Faiq MA; Kumari C; Narayan RK; Kulandhasamy M; Kant K
    Int Rev Immunol; 2021; 40(1-2):54-71. PubMed ID: 33111578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome.
    Dickel S; Grimm C; Amschler K; Schnitzler SU; Schanz J; Moerer O; Payen D; Tampe B; Winkler MS
    Front Immunol; 2021; 12():645124. PubMed ID: 33897692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune dysregulation and system pathology in COVID-19.
    Jamal M; Bangash HI; Habiba M; Lei Y; Xie T; Sun J; Wei Z; Hong Z; Shao L; Zhang Q
    Virulence; 2021 Dec; 12(1):918-936. PubMed ID: 33757410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
    England JT; Abdulla A; Biggs CM; Lee AYY; Hay KA; Hoiland RL; Wellington CL; Sekhon M; Jamal S; Shojania K; Chen LYC
    Blood Rev; 2021 Jan; 45():100707. PubMed ID: 32425294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female sex hormone, progesterone, ameliorates the severity of SARS-CoV-2-caused pneumonia in the Syrian hamster model.
    Yuan L; Zhu H; Wu K; Zhou M; Ma J; Chen R; Tang Q; Cheng T; Guan Y; Xia N
    Signal Transduct Target Ther; 2022 Feb; 7(1):47. PubMed ID: 35165265
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated frequencies of CD14
    Xue G; Jiang M; Zhao R; Le A; Li J
    Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.
    Kozma GT; Mészáros T; Bakos T; Hennies M; Bencze D; Uzonyi B; Győrffy B; Cedrone E; Dobrovolskaia MA; Józsi M; Szebeni J
    Front Immunol; 2021; 12():642860. PubMed ID: 33995361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Ahmed F; Jo DH; Lee SH
    Front Immunol; 2020; 11():586765. PubMed ID: 33365027
    [No Abstract]   [Full Text] [Related]  

  • 11. Is IL-6 a key cytokine target for therapy in COVID-19?
    Jones SA; Hunter CA
    Nat Rev Immunol; 2021 Jun; 21(6):337-339. PubMed ID: 33850327
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mardi A; Meidaninikjeh S; Nikfarjam S; Majidi Zolbanin N; Jafari R
    Viral Immunol; 2021 Dec; 34(10):679-688. PubMed ID: 34882013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 49th Annual Meeting of the Japanese Society for Immunology: COVID-19 and Immunity.
    Shinkura R; Kang S; Arase H; Toyama-Sorimachi N
    Int Immunol; 2021 Mar; 33(4):193-196. PubMed ID: 33538811
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement cascade in severe forms of COVID-19: Recent advances in therapy.
    Chouaki Benmansour N; Carvelli J; Vivier E
    Eur J Immunol; 2021 Jul; 51(7):1652-1659. PubMed ID: 33738806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).
    Tauber AL; Schweiker SS; Levonis SM
    Future Med Chem; 2021 Mar; 13(6):587-592. PubMed ID: 33467912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
    Alikhani M; Javadi A; Aalikhani M
    Iran J Immunol; 2021 Mar; 18(1):93-94. PubMed ID: 33787518
    [No Abstract]   [Full Text] [Related]  

  • 17. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
    Lu L; Zhang H; Dauphars DJ; He YW
    Trends Immunol; 2021 Jan; 42(1):3-5. PubMed ID: 33214057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
    Bellgrau D; Modiano JF
    Scand J Immunol; 2021 Mar; 93(3):e12979. PubMed ID: 32991014
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive immunogenetic markers in COVID-19.
    Leite MM; Gonzalez-Galarza FF; Silva BCCD; Middleton D; Santos EJMD
    Hum Immunol; 2021 Apr; 82(4):247-254. PubMed ID: 33546902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.
    Zhang J; Wu H; Yao X; Zhang D; Zhou Y; Fu B; Wang W; Li H; Wang Z; Hu Z; Ren Y; Sun R; Tian Z; Bian X; Wei H
    Cell Mol Immunol; 2021 May; 18(5):1305-1307. PubMed ID: 33742186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.